NiaXtend®

 

 

Cardiovascular Health, Healthy Aging, Metabolic Health, Energy & Focus

NiaXtend® is NutriScience’s innovative extended-release niacin, providing a unique delivery system that helps maintain healthy lipid profiles and normal cardiovascular function. Niacin, technically nicotinic acid, has long been studied for its ability to improve cholesterol levels, specifically by lowering LDL and increasing HDL levels, and for its role in energy metabolism. Unlike immediate-release niacin, NiaXtend® offers an extended-release tablet that enhances consumer tolerability by significantly reducing the common side effects of niacin including flushing, itching, and gastrointestinal distress, while at the same time enhancing the benefits of niacin. This tablet is ideal for use as a lipid management ready-to-package product aimed at promoting cardiovascular health and overall wellness.

Additionally, NiaXtend® is backed by NutriScience’s commitment to quality, exceptional technical support, and customer service.

 

K2Quest® is exclusively licensed to NutriScience Innovations, LLC.. (formerly licensed to XSTO).

Features & Benefits
  • Supports healthy cholesterol levels
  • Helps to lower LDL levels while significantly increasing HDL levels within the normal range
  • Promotes cardiovascular health
  • Helps support normal energy yielding metabolism
  • Increased tolerability compared to standard niacin
  • Extended-release format promotes health through all-day action
Applications
  • Cardiovascular support products
  • Triglyceride support products
  • Healthy aging products
  • Energy support products
  • Multi-pack nutraceutical formulations
Request Information
Mechanism of Action

NiaXtend® extended-release niacin reduces cholesterol levels through multiple mechanisms that target lipid metabolism. It inhibits hormone-sensitive lipase in adipose tissue, reducing the release of free fatty acids into the bloodstream. This leads to decreased triglyceride production in the liver, which in turn reduces the synthesis of very low-density lipoproteins (VLDL) and low-density lipoproteins (LDL). Niacin also increases lipoprotein lipase activity, enhancing the clearance of triglycerides from the blood.

Additionally, it decreases the hepatic production of ApoB, a key protein for VLDL and LDL formation, further lowering LDL levels. Niacin boosts high-density lipoprotein (HDL) levels by slowing HDL clearance, promoting reverse cholesterol transport. It also uniquely lowers lipoprotein(a), a genetic risk factor for cardiovascular disease. Overall, niacin improves lipid profiles by reducing LDL, triglycerides, and Lp(a), while increasing HDL cholesterol.

Scientific Studies

NiaXtend® has been scientifically and clinically studied across many benefit areas. The following health benefits are supported by these studies:

  • Reduction of LDL Cholesterol and Increase in HDL Cholesterol
  • Post-Prandial Lipid Management
  • Comparison to Inositol Hexanicotinate and Niacinamide
  • Energy Metabolism
  • Reduction of LDL Oxidation
Formulating with NiaXtend®

NiaXtend® is a proprietary, patented, vegetable-based extended-release wax matrix tablet available in 500 mg and 750 mg doses. They will dissolve in a slow and controlled manner releasing a minimum of 90% niacin by 7 hours of digestion. This helps to ensure optimal niacin absorption without the typical side effects caused by immediate release niacin. The 500 mg niacin-containing tablet weighs approximately 665 mg, while the 750 mg niacin-containing tablet weighs approximately 1,000 mg. The tablets are slightly mottled, off white, and round (500 mg) and oval (750 mg). The tablets have 5 years of shelf life.

Regulatory

NiaXtend® has been shown to be generally well tolerated, with lower incidences of flushing and gastrointestinal side effects (<10%) compared to immediate-release niacin. NiaXtend® is self-affirmed GRAS.

Item Code

NIAXTEND

Request more information
about NiaXtend®